| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/21/2002 | WO2001053340A3 Transgenic mouse model of human neurodegenerative disease |
| 02/21/2002 | WO2001053338A3 Cbp86, a sperm specific protein |
| 02/21/2002 | WO2001051629A3 Circularly permutated, interaction-activated proteins |
| 02/21/2002 | WO2001049832A3 Transduction of recombinases for inducible gene targeting |
| 02/21/2002 | WO2001046698A3 Tethered ligands and methods of use |
| 02/21/2002 | WO2001046397A3 Human kinases |
| 02/21/2002 | WO2001046232A3 Soluble interleukin-20 receptor |
| 02/21/2002 | WO2001044511A3 Methods and compositions for detection of mycobacterium avium complex species |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001043693A3 Polynucleotide vaccines expressing codon optimized hiv-1 nef and modified hiv-1 nef |
| 02/21/2002 | WO2001037654A3 METHOD OF EXPRESSING dsRNA IN PLANTS TO INHIBIT INSECT PESTS |
| 02/21/2002 | WO2001036623A3 Ecdysone-inducible adeno-associated virus expression vectors |
| 02/21/2002 | WO2001032871A3 Follistatin-related protein zfsta4 |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001029242A3 Post-translational modification of recombinant proteins produced in plants |
| 02/21/2002 | WO2001027306A3 Biosynthesis of polyketide synthase substrates |
| 02/21/2002 | WO2001027278A3 A member of the immunoglobulin superfamily and uses thereof |
| 02/21/2002 | WO2001023605A3 Method and nucleic acids for determining the presence of micro-organisms specific to the brewing process |
| 02/21/2002 | WO2001023586A3 Transacylases of the paclitaxel biosynthetic pathway |
| 02/21/2002 | WO2001023558A3 Human secretory molecules |
| 02/21/2002 | WO2000066148A9 Novel proteins |
| 02/21/2002 | WO2000061809A3 Methods and nucleic acid vectors for rapid and parallel assay development, for characterization of biological response modifiers |
| 02/21/2002 | WO2000060125A3 High resolution dna detection methods and devices |
| 02/21/2002 | US20020023282 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production |
| 02/21/2002 | US20020023279 Forages |
| 02/21/2002 | US20020023278 Genetic transformation in plants using site-specific recombination and wide hybridization |
| 02/21/2002 | US20020023276 Expression vectors for use in food processing; for use in the detction of cancer; for use in pre venting milk spoilage |
| 02/21/2002 | US20020023275 Transgenic mice containing matrix metalloprotease gene disruptions |
| 02/21/2002 | US20020022947 Simulator, method and recording medium for simulating a biological system |
| 02/21/2002 | US20020022719 Transgenic mice containing ubiquitin-specific protease gene disruptions |
| 02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
| 02/21/2002 | US20020022717 Using monoclonal antibodies |
| 02/21/2002 | US20020022715 Nervous system disorders; cardiovascular disorders; gastrointestinal disorders |
| 02/21/2002 | US20020022595 Treating inflammation resulting from a response of the non-specific defense system in a mammal by administering an antiinflammatory agent and the uncontaminated Mac-1 alpha subunit |
| 02/21/2002 | US20020022591 Polynucleotides and polypeptides comprising an ovarian tumor protein, antibodies directed against said polypeptides; diagnostic kits |
| 02/21/2002 | US20020022276 Individually addressable micro-electromagnetic unit array chips |
| 02/21/2002 | US20020022275 Cloning and copying on surfaces |
| 02/21/2002 | US20020022270 Human tissue cultures; inoculate vessel containing stromal tissue, continuously perfuse issue with nutrient broth, harvest preferential human tissue |
| 02/21/2002 | US20020022268 Culturing primate progenitor tissues; obtain tissues, harvest nutrients from culture, monitor tissue propagation |
| 02/21/2002 | US20020022259 Cardiac-cell specific enhancer elements and uses thereof |
| 02/21/2002 | US20020022258 Nucleotide sequences that codes enzymatic polypeptide; for use in the generation of disease resistant plants |
| 02/21/2002 | US20020022257 Three-dimensional structure and crystallization method of ribosome recycling factor (RRF) |
| 02/21/2002 | US20020022256 Polypeptide; for use in the generation of disease resistant plants |
| 02/21/2002 | US20020022255 Expresson vectors; for use as tool in genetic engineering and gene therapy |
| 02/21/2002 | US20020022254 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 02/21/2002 | US20020022249 Nucleotide sequences which code enzymatic polypeptide; for use in the diagnosis and treatment of cancer and blood disorders |
| 02/21/2002 | US20020022248 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 02/21/2002 | US20020022241 Detecting preferential immunoglobulins in solution; provide solid support, immoblize squalene on support, wash with blocking agent, incubate with test sample, incubate with ligand, incubate with indicator, detect indicator |
| 02/21/2002 | US20020022238 Genetically engineered microorganism for use as tools in the generation of heterologous binding proteins |
| 02/21/2002 | US20020022232 Computing fittings between sample nucleic acid and control; generate indicators, compute transformational adjustments, determine possible conformational patterns |
| 02/21/2002 | US20020022230 Compositions and methods for directly and rapidly analyzing the biochemical components of microorganisms |
| 02/21/2002 | US20020022228 Evaluating nucleotide sequence maintenance; provide nucleotide sequences, incubate with maintenance enzymes, monitor nucleotide sequence for enzymatic removal of preferential nucleotide sequences |
| 02/21/2002 | US20020022226 Method and device for detecting hybridization reaction |
| 02/21/2002 | US20020022224 Directly from double stranded PCR products by amplification using two oligonucleotide primers, one of which is tagged to form a tagged amplification product and a complementary non-tagged product, separation |
| 02/21/2002 | US20020022223 Screening for target nucleotide sequences; join oligonucleotide probes to electronic leads, incubate with target nucleotide sequences, hybridize, apply eletrical current, leads carring current indicates bound target |
| 02/21/2002 | US20020022222 Method of preparing a standard diagnostic gene transcript pattern |
| 02/21/2002 | US20020022111 Laminar structure overcoating substartes |
| 02/21/2002 | US20020022035 Genetic engineering; deactivating toxin |
| 02/21/2002 | US20020022034 Therapeutic DNA vaccination |
| 02/21/2002 | US20020022029 Human RRP sequences and methods of use |
| 02/21/2002 | US20020022028 Integrin antagonist; bone disorders |
| 02/21/2002 | US20020022027 Complexing to polypeptides; antiproliferation agent |
| 02/21/2002 | US20020022021 Method of regulating transcription in a cell |
| 02/21/2002 | US20020022018 Controlling gene expression |
| 02/21/2002 | US20020021299 Method for displaying results of hybridization experiment |
| 02/21/2002 | DE10127687A1 New DNA representing the Hero gene, for preparing transgenic plants resistant to Globodera cyst nematodes |
| 02/21/2002 | DE10110346A1 Neue für das IysR2-Gen kodierende Nukleotidsequenzen New coding for the IysR2 gene nucleotide sequences |
| 02/21/2002 | DE10109689A1 Neue für das metE-Gen kodierende Nukleotidsequenzen New coding for the metE gene nucleotide sequences |
| 02/21/2002 | DE10039043A1 Neue für das luxR-Gen kodierende Nukleotidsequenzen New coding for the luxR gene nucleotide sequences |
| 02/21/2002 | DE10038733A1 Verfahren zur Altersbestimmung von Individuen Method for determining the age of individuals |
| 02/21/2002 | DE10038573A1 Verfahren zur Selektion auf Wirtszellen mit eliminierten DNA-Sequenzen Process for the selection of host cells with DNA sequences eliminated |
| 02/21/2002 | DE10038382A1 Zweifarbiges fluorimetrisches Proteaseassay Two-toned fluorometric protease assay |
| 02/21/2002 | DE10036753A1 New amylolytic enzyme from Bacillus, useful e.g. in cleaning compositions and for starch liquefaction |
| 02/21/2002 | DE10036671A1 New nucleic acid encoding mitochondrial transporter, useful for preparing transgenic plants with e.g. altered protein content and improved germination |
| 02/21/2002 | DE10035292A1 Verfahren zur Gewinnung von Proteinen aus Pflanzen in reiner Form A process for the recovery of proteins from plant in pure form |
| 02/21/2002 | CA2457131A1 Oligonucleotides and other modulators of the nk-1 receptor pathway and therapeutic uses thereof |
| 02/21/2002 | CA2420037A1 Immunogenic hbc chimer particles having enhanced stability |
| 02/21/2002 | CA2419985A1 Modulating multiple lineage kinase proteins |
| 02/21/2002 | CA2419931A1 Inhibition of generative propagation in genetically modified grasses |
| 02/21/2002 | CA2419833A1 Inhibition of generative propagation in genetically modified herbicide resistant grasses |
| 02/21/2002 | CA2419790A1 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | CA2419725A1 Genes involved in immune related responses observed with asthma |
| 02/21/2002 | CA2419538A1 Polyketides and their synthesis |
| 02/21/2002 | CA2419533A1 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| 02/21/2002 | CA2419527A1 Arrayed collection of genomic clones |
| 02/21/2002 | CA2419524A1 Genes encoding mutant p-coumarate 3-hydroxylase (c3h) and methods of use |
| 02/21/2002 | CA2419505A1 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed |
| 02/21/2002 | CA2419491A1 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 02/21/2002 | CA2419481A1 Bioluminescent methods for direct visual detection of environmental compounds |
| 02/21/2002 | CA2419479A1 Transcription factor target gene discovery |
| 02/21/2002 | CA2419425A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
| 02/21/2002 | CA2419418A1 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | CA2419338A1 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
| 02/21/2002 | CA2419245A1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 02/21/2002 | CA2419203A1 Phage-dependent superproduction of biologically active protein and peptides |
| 02/21/2002 | CA2419182A1 Malaria immunogen and vaccine |
| 02/21/2002 | CA2419157A1 Improved insecticidal bacteria, and methods for making and using them |
| 02/21/2002 | CA2419133A1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |